Stem cells for amyotrophic lateral sclerosis modeling and therapy: Myth or fact?
- 2 February 2015
- journal article
- review article
- Published by Wiley in Cytometry Part A
- Vol. 87 (3) , 197-211
Abstract
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease whose pathophysiology is poorly understood. Aiming to better understand the cause of motor neuron death, the use of experimental cell‐based models increased significantly over the past years. In this scenario, much knowledge has been generated from the study of motor neurons derived from embryonic stem cells and induced pluripotent stem cells. These methods, however, have advantages and disadvantages, which must be balanced on experimental design. Preclinical studies provide valuable information, making it possible to combine diverse methods to build an expanded knowledge of ALS pathophysiology. In addition to using stem cells as experimental models for understanding disease mechanism, these cells had been quoted for therapy in ALS. Despite ethical issues involved in its use, cell therapy with neural stem cells stands out. A phase I clinical trial was recently completed and a phase II is on its way, attesting the method's safety. In another approach, mesenchymal stromal cells capable of releasing neuroregulatory and anti‐inflammatory factors have also been listed as candidates for cell therapy for ALS, and have been admitted as safe in a phase I trial. Despite recent advances, application of stem cells as an actual therapy for ALS patients is still in debate. Here, we discuss how stem cells have been useful in modeling ALS and address critical topics concerning their therapeutic use, such as administration protocols, injection site, cell type to be administered, type of transplantation (autologous vs. allogeneic) among other issues with particular implications for ALS therapy. © 2015 International Society for Advancement of CytometryKeywords
Funding Information
- FAPESP/CEPID
- INCT
This publication has 147 references indexed in Scilit:
- Protein aggregation in amyotrophic lateral sclerosisActa Neuropathologica, 2013
- Human Pericytes for Ischemic Heart RepairStem Cells, 2013
- Regulatory T‐lymphocytes mediate amyotrophic lateral sclerosis progression and survivalEMBO Molecular Medicine, 2012
- Blood–spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosisActa Neuropathologica, 2012
- Therapeutic opportunities: Telomere maintenance in inducible pluripotent stem cellsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2012
- Stem cell‐based cell therapy in neurological diseases: A reviewJournal of Neuroscience Research, 2009
- A Perivascular Origin for Mesenchymal Stem Cells in Multiple Human OrgansCell Stem Cell, 2008
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006
- Stem cells for the treatment of neurological disordersNature, 2006
- Directed Differentiation of Embryonic Stem Cells into Motor NeuronsCell, 2002